Published on
April 20, 2016
- 00:40 GMT
ReGenerCell(TM) Skin Regeneration Technology Decreases Size and Pain in Chronic Wounds
CAMBRIDGE, UNITED KINGDOM -- (Marketwired) -- 04/19/16 -- Avita Medical (OTCQX: AVMXY) (ASX: AVH) Clinical Data Shows ReGenerCell™ Significantly Decreases Wound Size and Patient Pain With Shorter Treatment Periods Approach Offers Great Potential Savings …
Distribution channels:
Healthcare & Pharmaceuticals Industry, Technology
...
